(NASDAQ: HCWB) Hcw Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.54%.
Hcw Biologics's earnings in 2026 is -$18,117,819.On average, 3 Wall Street analysts forecast HCWB's earnings for 2026 to be -$3,297,017, with the lowest HCWB earnings forecast at -$3,167,723, and the highest HCWB earnings forecast at -$3,393,988. On average, 3 Wall Street analysts forecast HCWB's earnings for 2027 to be -$3,022,266, with the lowest HCWB earnings forecast at -$2,903,746, and the highest HCWB earnings forecast at -$3,111,156.
In 2028, HCWB is forecast to generate -$2,404,075 in earnings, with the lowest earnings forecast at -$2,309,798 and the highest earnings forecast at -$2,474,783.